KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Total Non-Current Liabilities (2016 - 2025)

BeOne Medicines (ONC) has disclosed Total Non-Current Liabilities for 11 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 434.67% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 434.67% increase, with the full-year FY2025 number at $2.0 billion, up 434.67% from a year prior.
  • Total Non-Current Liabilities was $2.0 billion for Q4 2025 at BeOne Medicines, up from $1.1 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.0 billion in Q4 2025 to a low of -$3.6 billion in Q1 2025.
  • A 5-year average of $534.9 million and a median of $667.3 million in 2021 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: crashed 64.82% in 2022, then skyrocketed 434.67% in 2025.
  • BeOne Medicines' Total Non-Current Liabilities stood at $803.4 million in 2021, then plummeted by 34.35% to $527.4 million in 2022, then fell by 13.19% to $457.8 million in 2023, then decreased by 18.36% to $373.8 million in 2024, then surged by 434.67% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ONC's Total Non-Current Liabilities are $2.0 billion (Q4 2025), $1.1 billion (Q3 2025), and -$3.6 billion (Q1 2025).